Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis

European Neurology

Volumn 62, Issue 6, 2009, Pages 321-326

  Yaldizli, Özguer ^a   Kumar, Manoj ^b   Vago, Susanne ^c   Kreuzfelder, Erich ^b   Limmroth, Volker ^d   Putzki, Norman ^a,c  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d Cologne City Hospitals ^*  (Germany)

Author keywords

Fatigue; Immunological profile; Multiple sclerosis; Regulatory T cells

Indexed keywords

ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; MYELIN BASIC PROTEIN; POKEWEED MITOGEN;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; EX VIVO STUDY; FATIGUE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; FATIGUE; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 70049084592     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000236375     Document Type: Article

References (23)

1. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ: The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14.
2. Putzki N, Katsarava Z, Vago S, Diener HC, Limmroth V: Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. Eur Neurol 2008; 59: 136-142.
3. Hanson SJ, Gause W, Natelson B: Detection of immunologically significant factors for chronic fatigue syndrome using neural-network classifiers. Clin Diagn Lab Immunol 2001; 8: 658-662.
4. Natelson BH, LaManca JJ, Denny TN, Vladutiu A, Oleske J, Hill N, Bergen MT, Korn L, Hay J: Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am J Med 1998; 105: 43S- 49S.
5. Sabath DE, Barcy S, Koelle DM, Zeh J, Ashton S, Buchwald D: Cellular immunity in monozygotic twins discordant for chronic fatigue syndrome. J Infect Dis 2002; 185: 828-832. (Pubitemid 34226211)
6. Klimas NG, Salvato FR, Morgan R, Fletcher MA: Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403-1410.
7. Tirelli V, Pinto A, Marotta G, Crovato M, Quaia M, De Paoli P, Galligioni E, Santini G: Clinical and immunologic study of 205 patients with chronic fatigue syndrome: A case series from Italy. Arch Intern Med 1993; 153: 116-117, 120.
8. Chaudhuri A, Behan PO: Multiple sclerosis is not an autoimmune disease. Arch Neurol 2004; 61: 1610-1612.
9. Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM: Fatigue in multiple sclerosis: An example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 2006; 77: 34-39.
10. Bower JE, Ganz PA, Aziz N, Fahey JL: Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64: 604-611.
11. Lichtenstein GR, Bala M, Han C, DeWoody K, Schaible T: Infliximab improves quality of life in patients with Crohn's disease. Inflamm Bowel Dis 2002; 8: 237-243.
12. Kumar M, Putzki N, Limmroth V, Remus R, Lindemann M, Knop D, Mueller N, Hardt C, Kreuzfelder E, Grosse-Wilde H: CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J Neuroimmunol 2006; 180: 178-184.
13. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
14. Kohm AP, Carpentier PA, Anger HA, Miller SD: Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 2002; 169: 4712-4716.
15. Shevach EM: CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
16. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.
17. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY: Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22: 329-341.
18. Ditschkowski M, Kreuzfelder E, Rebmann V, Ferencik S, Majetschak M, Schmid EN, Obertacke U, Hirche H, Schade UF, Grosse- Wilde H: HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 1999; 229: 246-254.
19. Patarca R: Cytokines and chronic fatigue syndrome. Ann NY Acad Sci 2001; 933: 185-200.
20. Saresella M, Marventano I, Longhi R, Lissoni F, Trabattoni D, Mendozzi L, Caputo D, Clerici M: CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsingremitting multiple sclerosis and their modulation by therapy. FASEB J 2008; 22: 3500-3508.
21. Venken K, Hellings N, Broekmans T, Hensen K, Rummens JL, Stinissen P: Natural naive CD4+CD25+CD127 low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: Recovery of memory Treg homeostasis during disease progression. J Immunol 2008; 180: 6411-6420.
22. Natelson BH, Haghighi MH, Ponzio NM: Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin Diagn Lab Immunol 2002; 9: 747-752.
23. Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P: Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler 2004; 10: 165-169.